Evidence map›Paper›PMID 34285938›Full record

ArticleInternational journal of particle therapy2021

PTCOG Head and Neck Subcommittee Consensus Guidelines on Particle Therapy for the Management of Head and Neck Tumors.

Alexander Lin, John H C Chang, Ryan S Grover, Frank J P Hoebers, Upendra Parvathaneni, Samir H Patel, Juliette Thariat, David J Thomson, Johannes A Langendijk, Steven J Frank

Open access · diamondAbstract read
In one paragraph

Article in International journal of particle therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. ACR-ARS Practice Parameter for the Performance of Proton Beam Therapy.International journal of particle therapy · 2024
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 3 countries.

Alexander LinUniversity of Pennsylvania, Philadelphia, PA, USA.
John H C ChangOklahoma Proton Center, Oklahoma City, OK, USA.
Ryan S GroverUniversity of California-San Diego, San Diego, CA, USA.
Frank J P HoebersDepartment of Radiation Oncology (MAASTRO), GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.
Upendra ParvathaneniUniversity of Washington, Seattle, WA, USA.
Samir H PatelMayo Clinic, Scottsdale, AZ, USA.
Juliette ThariatRadiation Oncology Department, François Baclesse Center/ARCHADE, Normandy University, Caen, France.
David J ThomsonThe Christie NHS Foundation Trust, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, United Kingdom.
Johannes A LangendijkDepartment of Radiation Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Steven J FrankThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Maastricht University · NLMayo Clinic in Arizona · USThe Christie NHS Foundation Trust · GBThe University of Texas MD Anderson Cancer Center · USUniversity Medical Center Groningen · NLUniversity of California, San Diego · USUniversity of Pennsylvania · USUniversity of Washington · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeRadiation therapy is a standard modality in the treatment for cancers of the head and neck, but is associated with significant short- and long-term side effects. Proton therapy, with its unique physical characteristics, can deliver less dose to normal tissues, resulting in fewer side effects. Proton therapy is currently being used for the treatment of head and neck cancer, with increasing clinical evidence supporting its use. However, barriers to wider adoption include access, cost, and the need for higher-level evidence.

methodsThe clinical evidence for the use of proton therapy in the treatment of head and neck cancer are reviewed here, including indications, advantages, and challenges.

resultsThe Particle Therapy Cooperative Group Head and Neck Subcommittee task group provides consensus guidelines for the use of proton therapy for head and neck cancer.

conclusionThis report can be used as a guide for clinical use, to understand clinical trials, and to inform future research efforts.

Indexed as

head and neck cancerproton therapy

Identifiers

PMID34285938
PMCPMC8270078
OpenAlexW3176821518

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.